Lifesci Venture Management, LLC
LifeSci Venture Partners III, LP
Late investment period: first sale Jul 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $38.69M to $39.38M (Form D and SEC adviser filing)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
LifeSci Venture Partners invests in clinical-stage medical companies, seeking transformational models in molecular medicine, technology, or healthcare delivery. It targets proof-of-concept companies with a path to public markets within 12-18 months and offers founder-aligned terms.Inferred from the firm's website
02 · Initial check
$387K to $656K (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
No partners identified yet.
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideLifeSci Venture Partners describes itself as collaborative capital that accelerates medical breakthroughs, focusing on clinical-stage companies.
Collaborative capital that accelerates medical breakthroughs.
https://lifesciventure.com/
06 · Sources
Last verified: Oct 28, 2026